RBx, What do make of this, according to FDA government websites both DARRT and CEP trials are still recruiting, is Noxopharm in breach of reporting protocols and misleading information to investors or do you think that the trials are still going ?
ClinicalTrials.gov Identifier: NCT04957290
1
Recruitment Status: Recruiting
First Posted: July 12, 2021
Last Update Posted: January 30, 2023
1
ClinicalTrials.gov Identifier: NCT05100628
2
Recruitment Status: Recruiting
First Posted: October 29, 2021
Last Update Posted: July 13, 2022
NOX Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
